Reyn Pharma, LLC
Records under this name other than patents Reyn Pharma, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 8 of 8 · Back to Reyn Pharma, LLC
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,056,121 | Method of administering hyaluronan formulation for the amelioration of osteophytes Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,993,496 | Method of administering hyaluronan formulation for supporting joint health Formerly held Lapsed on the fee record Ended Jun 12, 2026 · USPTO record | Lapsed on the fee record | Ended Jun 12, 2026 | USPTO record |
| US 8,598,144 | Method of administering hyaluronan formulation for the amelioration of osteoarthritis Formerly held Lapsed on the fee record Ended Dec 3, 2025 · USPTO record | Lapsed on the fee record | Ended Dec 3, 2025 | USPTO record |
| US 9,433,575 | Method of administering hyaluronan formulation for preventing and ameliorating osteoarthritis Formerly held Lapsed on the fee record Ended Sep 6, 2024 · USPTO record | Lapsed on the fee record | Ended Sep 6, 2024 | USPTO record |
| US 9,492,381 | Method of administering hyaluronan formulation for preventing and ameliorating osteoarthritis Formerly held Term ended Term ended Jul 17, 2024 · USPTO record | Term ended | Term ended Jul 17, 2024 | USPTO record |
| US 8,178,511 | Method of administering hyaluronan formulation for the amelioration of osteopenia Formerly held Lapsed on the fee record Ended May 15, 2024 · USPTO record | Lapsed on the fee record | Ended May 15, 2024 | USPTO record |
| US 8,163,716 | Method of administering hyaluronan formulation for the amelioration of osteophytes Formerly held Lapsed on the fee record Ended Apr 24, 2024 · USPTO record | Lapsed on the fee record | Ended Apr 24, 2024 | USPTO record |
| US 10,583,153 | Method of administering hyaluronan formulation for maintaining and supporting joint health Formerly held Lapsed on the fee record Ended Mar 10, 2024 · USPTO record | Lapsed on the fee record | Ended Mar 10, 2024 | USPTO record |